Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

The MassDevice Big 100 The MassDevice Big 100 details the world's 100 largest medical device players, ranked by 2010 revenues. The book features: Company
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for May 22, 2015

May 22, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Lumicell receives FDA nod for feasibility trial

May 22, 2015 by Fink Densford

Lumicell says it received approval from the FDA for a pilot feasibility study of its intraoperative breast cancer imaging system.

Lumicell receives nod from FDA for feasibility trial

Lumicell Diagnostics said it won an investigational device exemption from the FDA for a pilot feasibility trial of its imaging system for breast cancer surgeries.

The study is slated to be conducted at the Mass. General Hospital in Boston, the company said.

Warburg Pincus takes majority stake in Sterigenics

May 22, 2015 by Fink Densford

Private equity firm Warburg Pincus takes out a majority stake in contract sterilization company Sterigenics.

Warburg Pincus takes majority stake in Sterigenics

Private equity firm Warburg Pincus acquired a majority stake in contact sterilization provider Sterigenics International, according to GTCR, which bought the company in 2011.

On-X Life Technologies launches mitral valve chord repair system

May 22, 2015 by Fink Densford

On-X Life Technologies says it's launching a mitral valve chordal repair system, dubbed Chord-X.

On-X Life Technologies launches mitral valve chord repair system

On-X Life Technologies said it's launching Chord-X, a new mitral valve chordal repair system using the company's proprietary sutures.

Ocular Therapeutix presses ahead with eye drug-device combo

May 22, 2015 by Fink Densford

Ocular Therapeutix says it's filing a new drug application with the FDA to broaden the indication for its flagship OTX-DB ocular pain drug, now named Dextenza.

Ocular Therapeutix presses ahead with eye drug-device combo

NeuWave Med raises $25m

May 22, 2015 by Mark Hollmer

NeuWave Medical raised more than $25 million in equity financing as it works to advance the market for its microwave ablation tumor removal tool.

NeuWave Med raises $25m

NeuWave Medical – developer of a microwave ablation tumor removal tool – has pulled in more than $25.3 million in new equity financing.

Medtech funding in today's environment

May 22, 2015 by Scott Wooldridge

Although it's a challenge for new medical device companies to arrange financing, there are funding opportunities out there for medtech startups willing to look beyond venture capital.

Medtech funding in today's environment

Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis.

The panel, "Financing Opportunities in Today's Marketplace," discussed venture capital, IPOs, strategic investors and the important role played by a board of directors play.

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board

May 22, 2015 by Fink Densford

Replacement heart valves once again take center stage at the annual EuroPCR conference in Paris this week, as Edwards Lifesciences pauses its Fortis trial and positive new data comes in on the next generation of aortic implants.

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board